ArticleSurgical endoscopy2026
Endohepatology in clinical practice: EUS-guided cyanoacrylate embolisation of gastroesophageal varices supplied by the gastric coronary vein.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo investigate the safety and efficacy of treating gastroesophageal varices by gastric coronary vein puncture cyanoacrylate selective seal (PCSS) under endoscopic ultrasound.
methodsCirrhotic patients with esophagastric varices undergoing endotherapy for secondary prophylaxis in our centre were retrospectively included and analysed. The primary evaluation indicators were the eradication rate of varices and variceal rebleeding. The secondary evaluation indicator was reinterventions.
resultsA total of 46 patients were included in the study. All procedures were technically successful in all patients. Esophagastric varices were eradicated in 39 patients (92.86%) according to contrast-enhanced computed tomography re-examination within 1 month after the procedure. No symptoms or signs of cyanoacrylate embolisation related to the procedure were observed. Rebleeding occurred in two patients (4.76%) during a median follow-up period of 676 days (95% CI 665-688 days).
conclusionPCSS enables optimal visualisation of gastroesophageal varices and their feeding vessels and precise delivery of cyanoacrylate embolisation. The technique demonstrates a satisfactory degree of both effectiveness and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.